Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 9 | 0 | 1.072,0 € | 1.091,9 € | 1,86 % |
| Eli Lilly Corp. | 68 | 0 | 9 | 0 | 867,80 € | 883,50 € | 1,81 % |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 7 | 0 | 448,50 € | 450,36 € | 0,42 % |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | 321,70 € | 418,12 € | 29,97 % |
| United Therapeutics | 27 | 1 | 5 | 1 | 329,00 € | 341,51 € | 3,80 % |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | 223,80 € | 315,00 € | 40,75 % |
| Amgen Inc. | 28 | 0 | 3 | 0 | 301,95 € | 304,82 € | 0,95 % |
| Biogen Inc. | 51 | 2 | 5 | 1 | 185,20 € | 284,87 € | 53,82 % |
| Alnylam Pharmace. | 46 | 1 | 8 | 1 | 237,70 € | 271,50 € | 14,22 % |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | 178,90 € | 247,61 € | 38,41 % |
| Zoetis Inc. A | 25 | 1 | 4 | 0 | 166,00 € | 198,11 € | 19,34 % |
| Johnson & Johnson | 40 | 1 | 2 | 0 | 150,02 € | 187,62 € | 25,06 % |
| Krystal Biotech | 20 | 0 | 4 | 0 | 176,40 € | 185,58 € | 5,20 % |
| AbbVie Inc. | 34 | 0 | 3 | 0 | 177,58 € | 181,45 € | 2,18 % |
| Repligen Corp. | 15 | 0 | 3 | 0 | 130,50 € | 178,01 € | 36,41 % |
| Neurocrine Bioscience | 45 | 0 | 10 | 0 | 115,00 € | 149,74 € | 30,21 % |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | 125,00 € | 130,00 € | 4,00 % |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | 107,20 € | 125,91 € | 17,45 % |
| Abbott Laboratories | 20 | 0 | 2 | 0 | 102,48 € | 116,25 € | 13,43 % |
| BioMarin Pharmaceutical Inc. | 23 | 0 | 7 | 0 | 82,52 € | 102,48 € | 24,18 % |
| Gilead Sciences Inc | 12 | 1 | 1 | 0 | 71,46 € | 84,81 € | 18,68 % |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | 51,00 € | 84,74 € | 66,16 % |
| Intra-Cellular Therapies Inc. | 31 | 0 | 3 | 0 | 66,50 € | 84,73 € | 27,41 % |
| Cytokinetics Inc. | 30 | 1 | 1 | 0 | 52,00 € | 84,53 € | 62,56 % |
| Prothena Corp. plc | 13 | 0 | 2 | 0 | 19,10 € | 78,70 € | 312,04 % |